Weiss-Messer E, Ber R, Amit T, Barkey R J
Department of Pharmacology, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa.
Mol Cell Endocrinol. 1998 Aug 25;143(1-2):53-64. doi: 10.1016/s0303-7207(98)00134-8.
The aim of this study is to further characterize the prolactin receptors (PRL-R) previously reported in the murine Leydig tumor MA-10 cell line, as well as to study their homologous and heterologous regulation. Two forms of PRL-R, a high and a low molecular weight form, were revealed by studies of covalent crosslinking of 125I-human GH to cultured MA-10 cells or cell membranes and immunoprecipitation of the solubilized PRL-R complexes with polyclonal anti PRL-R antibody, followed by SDS-PAGE and autoradiography. The long form had a molecular weight of 101 kDa and was predominant when the study was performed in the presence of protease inhibitors. The short form, with a molecular weight of 39 kDa, appeared, at least in part, to be a proteolytic product of the longer form. The same size forms of PRL-R were detected by crosslinking studies in the parental C57BL/6 mouse testicular Leydig cells, indicating the physiological relevance of the MA-10 cell model to the study of Leydig cell PRL-R. Homologous down-regulation of PRL-R was demonstrated in cultured MA-10 cells exposed for 24 h to increasing concentrations of PRL. In contrast, heterologous, 3 5-fold up-regulation of PRL-R was induced by various cAMP-elevating agents, including 8-bromo-cAMP (10(-4) -10(-3) M), dibutyryl cAMP (3 x 10(-3) M) and cholera toxin (1-10 ng/ml), although not by hCG (up to 100 ng/ml). This up-regulatory effect was apparently the result of a change in affinity, since cholera toxin caused a 2.4-fold increase in PRL-R affinity, with no change in the number of binding sites. In summary, these studies provide further evidence that MA-10 Leydig cells can serve as a physiologically relevant model for the study of PRL and PRL-R interactions, both at the functional level, as shown in our previous study, and at the structural and regulatory levels as shown in the current study.
本研究的目的是进一步表征先前在小鼠睾丸间质细胞瘤MA - 10细胞系中报道的催乳素受体(PRL - R),并研究其同源和异源调节。通过将¹²⁵I - 人生长激素与培养的MA - 10细胞或细胞膜进行共价交联,并用多克隆抗PRL - R抗体对溶解的PRL - R复合物进行免疫沉淀,随后进行SDS - PAGE和放射自显影,揭示了两种形式的PRL - R,即高分子量形式和低分子量形式。长形式的分子量为101 kDa,在有蛋白酶抑制剂存在的情况下进行研究时占主导地位。短形式的分子量为39 kDa,至少部分似乎是长形式的蛋白水解产物。通过交联研究在亲代C57BL / 6小鼠睾丸间质细胞中检测到相同大小形式的PRL - R,表明MA - 10细胞模型对于研究间质细胞PRL - R具有生理相关性。在暴露于浓度不断增加的PRL 24小时的培养MA - 10细胞中证实了PRL - R的同源下调。相反,各种升高cAMP的试剂,包括8 - 溴 - cAMP(10⁻⁴ - 10⁻³ M)、二丁酰cAMP(3×10⁻³ M)和霍乱毒素(1 - 10 ng/ml)可诱导PRL - R的异源上调3 - 5倍,尽管hCG(高达100 ng/ml)不能诱导。这种上调作用显然是亲和力变化的结果,因为霍乱毒素使PRL - R亲和力增加了2.4倍,而结合位点数量没有变化。总之,这些研究提供了进一步的证据,表明MA - 10间质细胞可以作为研究PRL和PRL - R相互作用的生理相关模型,在功能水平上如我们先前的研究所显示,在结构和调节水平上如本研究所显示。